Company Overview of Cardioxyl Pharmaceuticals, Inc.
Cardioxyl Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies and technologies for the treatment of cardiovascular diseases. It offers nitroxyl therapeutics, including CXL-1020, a nitroxyl donor compound for the intravenous treatment of acute decompensated heart failure; and nitroxyl donor compounds for unmet medical needs in other cardiovascular indications. The company was founded in 2005 and is based in Chapel Hill, North Carolina.
1450 Raleigh Road
Chapel Hill, NC 27517-8833
Founded in 2005
Key Executives for Cardioxyl Pharmaceuticals, Inc.
Cardioxyl Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|BioSystem Development, LLC||United States|
|Epicentre Technologies Corporation||United States|
|Light Sciences Oncology, Inc.||United States|
|AMS Sciences Limited||United States|
|Phage International, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
- Detroit, MI | RecruitarrowPosted: Dec 12
- Phoenix, AZ | Cardinal HealthPosted: Dec 12
Sponsored Financial Commentaries
To contact Cardioxyl Pharmaceuticals, Inc., please visit www.cardioxyl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.